Member Info for Troutisout1

They weren't free shares they exercised at 0.1p so they cost him £6,440, the difference between that and the value they are, becomes subject to income tax/NI. Any gain on the remaining shares would be subject to CGT.

So what is Mo's Income tax rate?, What is CGT for someone in that income tax bracket? Are there ways of mitigating some of the tax implications either income tax and CGT?

Then you can see why he has done this now and just before the end of the tax year, when most people are trying to sort out their tax affairs.

Laura Trump of the PYC board, they post a load of untrue comments and then if someone points out the real facts they either try and deflect or say they put on filter...Hopefully anyone reading can see what Laura is all about, for some the dawning reality of following such a poster has cost them dear, don't worry about Laura though while posting constant ramping there will have been a lot of trading going on behind your backs...

If you do a bed and ISA/SIPP, you don't do it a the highest price you try and get the lowest price to reduce the tax and increase the potential.

Another thing that no-one has mentioned is that a 3m overhang has just been cleared...

By exercising them at a lower level the tax will less, if he exercises at twice the price the tax would double, this way he can use tax free vehicles ISAs, Pension to mitigate the tax and if it does double again then he will have saved himself lots of tax, that's what most shrewd investors do....

£500k of contracts from July -Dec 2024 to be carried forward (stronger second half of the year mentioned in today's RNS)

-There were £500k of contracts carried over from last year to H1, do the maths but it is clear some of these are being carried forward again....

Cash now of £700,000 v market cap £1.3mln

-Cash will not be £700k because the £500k they raised was gross before expenses and they have had over 2 months of this year spending some of the cash that was in the bank on 31st December 2024...

Charts most oversold in 12mths

-You said that when it was at 0.49p and it has still gone down again....

Dosing tool nearly ready "final sprint"

-It is not nearly ready to monetise, it is nearly ready to be tested by some DosemeRX clients, it is a long way away from being a finished product and being monetised....

Late stage contract

-What late stage contract???

A.I medicine

-Everyone is doing AI medicine nowadays.....

TR1 buyer suggested adding more in new ISA

-The TR1 buyer who has lost two thirds of his investment in a month....

So as everyone can see now, H1 didn't see the pipeline of contracted work turn into the expected revenues, some of this now seems to be carried over for H2.

Revenues down and losses up, now that confirms why they had to do the placing before the Interims were published.

DosemeRX tool still being tweaked before going out to Physicians for testing (unlike what some posters here were saying) and still a way off being a monetised offering.

The cash figure at H1 end will have dwindled due to another 2 months of costs and the placing proceeds of £500k would probably be 12-15% lower after costs (so it certainly won't be £700k).

The caveat that new contracts aren't guaranteed to be signed by year end suggests they aren't that 'late stage' and still bear some risks of not happening.

The Company burnt through £330k of cash in H1, if revenues increase so will costs and the important factor is the loss/profit made on this extra revenue.

This certainly hasn't turned the corner yet and what seemed like some slippage into this year, turns out to be a constant slippage on going, from signing contracts to achieving and receiving revenues from those contracts is taking too long.

I don't think the company has a big enough critical mass, the size of contracts are negated by having to hire in people to work on those contracts and at the levels we are talking they are never going to get out of that trap, so perhaps a trade sale may be a way forward, but if not then I can only see more of the same from the last couple of years and with AI exploding and the emphasis on mathematical modelling the bigger companies will develop this themselves at a far cheaper cost than PYC can continue to develop to keep up.

7 weeks ago, Laura was spouting this, the list posted today has changed, the fact it is littered with falsehoods hasn't changed. Laura you are not being honest with people....

"Laura2022

Posted in: PYC

Posts: 8,166

Price: 0.825

No Opinion

If people read15 Jan 2025 09:01

Looks like disrupting from people

They clearly ar fully funded as said after June and in full year report with almost £600k versus £1.5mln cap and largest revenues recorded for H1 June 2024 to Dec 2024"

I wouldn't get too hung up on monetary cut offs for RNSs, a contract can be material on more than just value, a new major client, a new revenue stream or the first contract of a new platform can all warrant an RNS.

Laura, you always seem to cut the full message short,

"The Company is actively discussing a number of further contracts although there is no guarantee they will be signed within the current financial year. "

And you bought in the WRAP offer?

We are less than 4 weeks from year end, let's hope that the Company can continue as they did in the first half and bring in the revenues needed for people to see they have turned this around and are 'thriving'.

The order book is important but the revenue is more so for those looking in.

Not Wishbone???

CHEATED,

You do know how much that would cost to list on either? Totally not an option at this time. Be patient, the market will catch up and in the meantime those ahead of the curve can keep adding...

Justdandy,

I am quite aware of the attractions of Redmoor, my post was in reference to those about dodgy food practices and a US trade deal.

I certainly don't need to wake up or smell the coffee or be schooled by you, but thanks for your concern.

Has Laura managed to encourage an even bigger ramper onto this BB......

As I understand it they were talking about quite a narrow trade deal, mainly in the technology sector.

Oldsharedog,

"The interim figures are expected to show less of a loss as detailed in the previous RNS 30.1 - The Board also expects the Company's loss after tax for the same period will be slightly lower than current expectations."

The RNS of 30/1 only stated expectations for the full year, not for the Interims. It seemed strange at the time, to make predictions on a period which 5 months of it was in the future, rather than do what most would and give a trading update for the Half Year where all the figures would be known, as they were historical.

4 working days until Interims, everyone will be looking forward to seeing them, especially Laura.

So anyway Laura, you always go on about others not answering your questions, how about my one?

"Anyway, let's discuss the company here, what do you feel the Interim figures will show, we have seen your list of bull points and can now see most of those are incorrect, but what revenue and profit/loss figure do you think they will post for H1?"

"The Board expects that total income for the current financial year, driven by contracts already signed, will be in line with market expectations. The Company is actively discussing a number of further contracts although there is no guarantee they will be signed within the current financial year. "

The above from the trading statement caveats that they might not be signed within the current financial year, let alone bring in any revenue in that time. That ends on 30th June this year, their guidance in the same RNS refers to 'driven by contracts already signed', so again suggesting that they are uncertain of anything more for the first half of 2025.

Any CROs that are not permanently discussing contracts would soon be bust, it is getting them signed and delivered and paid for that counts, it would seem PYC is struggling again with slippage on this front.

Interims in the next fortnight will confirm how the first half went, but remember there was a large contracted order book overhang from the previous trading year, so drawing comparisons is even harder.

SolVista,

You miss out the bit about the Covid rally, awash with most people using their furlough money and the subsequent drop was when that froth settled and everyone bailed out. Not really HVO specific...